March 26, 2009 -Takeda Pharmaceutical Company Limited today announced its submission of an application of the additional indication of “Takepron® Capsules 15” and “Takepron® OD Tablets 15” to the Ministry of Health, Labour and Welfare for prevention of onset of low-dose aspirin related gastric and duodenal ulcer. Takepron is a proton pump inhibitor discovered by Takeda and has been launched since 1992 in Japan.
the details can be read here.
No comments:
Post a Comment